Bio-Rad Expands Its Multiplex Immunoassays

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today announced the launch of the Bio-Plex Pro™ Human Apolipoprotein Panel. This 10-plex panel allows researchers to rapidly detect and quantify key human apolipoproteins associated with cardiovascular disease, especially within the statin pathway, as well as the widely used biomarker C-reactive protein. The panel, which offers the largest number of apolipoproteins on the market, includes four targets (Apo C1, Apo D, Apo J, and Apo H) not found on other multiplex panels. “The Bio-Plex Pro Apolipoprotein Panel is not only the most comprehensive apolipoprotein assay available, it also allows researchers to detect more samples than any other assay on the market, leading to clear and actionable results,” said Brett Houser, Bio-Plex Global Product Manager, Bio-Rad. Detecting changes in apolipoprotein levels can be difficult with traditional ELISA techniques because they require a large sample input. The Bio-Plex Pro Apolipoprotein Panel offers a multiplex solution ...